Stryker Corp. Stock
€316.00
Your prediction
Stryker Corp. Stock
Pros and Cons of Stryker Corp. in the next few years
Pros
Cons
Performance of Stryker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Stryker Corp. | 0.860% | 6.326% | 5.193% | -10.810% | 5.474% | 29.908% | 58.491% |
| Zimmer Holdings | -0.320% | 3.852% | 0.504% | -18.902% | 3.771% | -32.062% | -39.084% |
| Dexcom Inc. | -1.480% | 1.972% | 1.507% | -25.306% | 1.029% | -43.513% | -27.020% |
| Baxter International | 2.260% | 8.810% | 15.945% | -36.891% | 11.134% | -56.533% | -72.907% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.The financial performance of Stryker Corporation (SYK) in the Healthcare Equipment & Supplies industry presents a mixed bag of strengths and weaknesses. The company has showcased significant growth in revenues and net income over the past few years, demonstrating resilience in an evolving market. However, challenges related to profitability margins and high valuation ratios suggest a careful approach to investment. Let’s delve deeper into the key components of the financials to get a clearer picture of Stryker’s financial health.
*Pros: *
Revenue Growth: Stryker exhibited robust revenue growth year-over-year, going from $17.1 billion in 2021 to approximately $20.5 billion in 2023. This growth can be attributed to increasing demand for medical devices, innovations, and the company’s broad product portfolio, which includes surgical equipment, neurotechnology, and spine products.
Comments
News
Why Stryker Stock Popped Today
Stryker (NYSE: SYK) stock is hopping Tuesday morning, up 3.2% through 11:45 a.m. ET, after Raymond James analyst Jayson Bedford called the company "one of the highest quality stocks in large cap
3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most
Major players in healthcare are increasing their commitments to return capital to shareholders, resulting in significantly higher dividends. Recent dividend announcements from major companies in
Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?
Over $500 million in insider stock sales have hit three high-profile companies this month—an unsettling signal that even top executives and major stakeholders may be questioning the sustainability